DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Mylan Inc. (NASDAQ: MYL)

57.51 0.68 (1.20%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MYL $57.51 1.20%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $56.80
Previous Close $56.83
Daily Range $56.56 - $57.83
52-Week Range $41.79 - $59.60
Market Cap $21.5B
P/E Ratio 24.60
Dividend (Yield) $0.00 (0.0%)
Volume 7,722,238
Average Daily Volume 3,338,026
Current FY EPS $3.57

Sector

Healthcare

Industry

Drugs

Mylan Inc. (MYL) Description

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients. Website: http://www.mylan.com/

News & Commentary

3 Cheap Dividend Stocks That Could Be Top Stocks in 2015

Owens & Minor, Kindred Healthcare, and Teva Pharmaceuticals are three dividend-paying companies that could reward investors next year.

Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog

Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog

Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio

Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog

Teva's (TEVA) 2015 Guidance Hit By Generics - Analyst Blog

Teva's (TEVA) 2015 Guidance Hit By Generics - Analyst Blog

Actavis Likely to Continue Selling Namenda IR Tablets - Analyst Blog

Mylan Among First to Launch Generic Celebrex - Analyst Blog

Supernus Faces another Patent Challenge for Oxtellar XR - Analyst Blog

Health Care Sector Update for 12/11/2014: ARIA, STJ, KITE, MYL

Mylan Launches First Generic Version Of Orapred ODT

Supernus Faces New Patent Challenge for Trokendi XR - Analyst Blog

See More MYL News...

MYL's Top Competitors

MYL $57.51 (1.20%)
Current stock: MYL
JNJ $105.55 (-1.18%)
Current stock: JNJ
NVS $94.61 (0.04%)
Current stock: NVS
RHHBY $34.47 (-6.59%)
Current stock: RHHBY